Granulomatosis With Polyangiitis in Untreated Graves' Disease: A Rare Event
- PMID: 36340518
- PMCID: PMC9621745
- DOI: 10.7759/cureus.29742
Granulomatosis With Polyangiitis in Untreated Graves' Disease: A Rare Event
Abstract
Antithyroid medications can cause antineutrophil cytoplasmic antibody (ANCA) vasculitis. However, no literature in English describes the coexistence of granulomatosis with polyangiitis (GPA) and untreated Graves' disease. We present a 19-year-old female with thyroid storm and additional complaints of cough, hemoptysis, nasal discharges, polyarthralgia, and skin lesions. Imaging showed peri-hilar cavities and acute-on-chronic sinusitis. Elevated cytoplasmic pattern antineutrophil cytoplasmic antibody (C-ANCA) and anti-proteinase-3 antibody levels plus histopathology of the nasal and skin biopsies suggested GPA. Propranolol, methimazole, and potassium-iodide resolved the thyroid storm. Induction therapy (steroids, rituximab) for GPA provided relief of chronic symptoms stressing the importance of early recognition and swift initiation of treatment.
Keywords: anca associated vasculitis; coexistence; granulomatosis with polyangiitis (gpa); graves´disease; rituximab therapy; thyroid-storm.
Copyright © 2022, Moosa et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Clinical practice. Graves' disease. Brent GA. N Engl J Med. 2008;358:2594–2605. - PubMed
-
- Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease. Pillinger M, Staud R. Semin Arthritis Rheum. 1998;28:124–129. - PubMed
-
- Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Stone JH. Arthritis Rheum. 2003;48:2299–2309. - PubMed
-
- Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Sera N, Ashizawa K, Ando T, et al. Thyroid. 2000;10:595–599. - PubMed
-
- Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. Gumà M, Salinas I, Reverter JL, Roca J, Valls-Roc M, Juan M, Olivé A. J Clin Endocrinol Metab. 2003;88:2141–2146. - PubMed
Publication types
LinkOut - more resources
Full Text Sources